Author: Publisher:
ISBN: 9781731952295
Category : Drugs
Languages : en
Pages : 0
Book Description
Guide to Biosimilars Litigation and Regulation in the U.S.
Author: Robert V. CerwinskiPublisher:
ISBN: 9781539286721
Category : Drugs
Languages : en
Pages : 686
Book Description
Guide to Biosimilars Litigation and Regulation in the U.S.
Author: Biosimilars Litigation and Client Counseling
Author: Kenneth L. DorsneyPublisher:
ISBN: 9781639054657
Category : Attorney and client
Languages : en
Pages : 0
Book Description
"A practitioner's quick reference guide for the biosimilars field"--
Promoting Access to Medical Technologies and Innovation - Intersections between Public Health, Intellectual Property and Trade
Author: World Intellectual Property OrganizationPublisher: WIPO
ISBN: 9280523082
Category : Law
Languages : en
Pages : 259
Book Description
This study has emerged from an ongoing program of trilateral cooperation between WHO, WTO and WIPO. It responds to an increasing demand, particularly in developing countries, for strengthened capacity for informed policy-making in areas of intersection between health, trade and IP, focusing on access to and innovation of medicines and other medical technologies.
Making Medicines Affordable
Author: National Academies of Sciences, Engineering, and MedicinePublisher: National Academies Press
ISBN: 0309468086
Category : Medical
Languages : en
Pages : 235
Book Description
Thanks to remarkable advances in modern health care attributable to science, engineering, and medicine, it is now possible to cure or manage illnesses that were long deemed untreatable. At the same time, however, the United States is facing the vexing challenge of a seemingly uncontrolled rise in the cost of health care. Total medical expenditures are rapidly approaching 20 percent of the gross domestic product and are crowding out other priorities of national importance. The use of increasingly expensive prescription drugs is a significant part of this problem, making the cost of biopharmaceuticals a serious national concern with broad political implications. Especially with the highly visible and very large price increases for prescription drugs that have occurred in recent years, finding a way to make prescription medicinesâ€"and health care at largeâ€"more affordable for everyone has become a socioeconomic imperative. Affordability is a complex function of factors, including not just the prices of the drugs themselves, but also the details of an individual's insurance coverage and the number of medical conditions that an individual or family confronts. Therefore, any solution to the affordability issue will require considering all of these factors together. The current high and increasing costs of prescription drugsâ€"coupled with the broader trends in overall health care costsâ€"is unsustainable to society as a whole. Making Medicines Affordable examines patient access to affordable and effective therapies, with emphasis on drug pricing, inflation in the cost of drugs, and insurance design. This report explores structural and policy factors influencing drug pricing, drug access programs, the emerging role of comparative effectiveness assessments in payment policies, changing finances of medical practice with regard to drug costs and reimbursement, and measures to prevent drug shortages and foster continued innovation in drug development. It makes recommendations for policy actions that could address drug price trends, improve patient access to affordable and effective treatments, and encourage innovations that address significant needs in health care.
FDA Approved Animal Drug Products
Author: Biologics, Biosimilars, and Biobetters
Author: Iqbal RamzanPublisher: John Wiley & Sons
ISBN: 1119564654
Category : Medical
Languages : en
Pages : 328
Book Description
A comprehensive primer and reference, this book provides pharmacists and health practitioners the relevant science and policy concepts behind biologics, biosimilars, and biobetters from a practical and clinical perspective. Explains what pharmacists need to discuss the equivalence, efficacy, safety, and risks of biosimilars with physicians, health practitioners, and patients about Guides regulators on pragmatic approaches to dealing with these drugs in the context of rapidly evolving scientific and clinical evidence Balances scientific information on complex drugs with practical information, such as a checklist for pharmacists
Pharmacy Practice and the Law
Author: Richard R. AboodPublisher: Jones & Bartlett Learning
ISBN: 9780763732981
Category : Drugs
Languages : en
Pages : 396
Book Description
Pharmacy Practice
Drug Wars
Author: Robin FeldmanPublisher: Cambridge University Press
ISBN: 131673949X
Category : Law
Languages : en
Pages : 165
Book Description
While the shockingly high prices of prescription drugs continue to dominate the news, the strategies used by pharmaceutical companies to prevent generic competition are poorly understood, even by the lawmakers responsible for regulating them. In this groundbreaking work, Robin Feldman and Evan Frondorf illuminate the inner workings of the pharmaceutical market and show how drug companies twist health policy to achieve goals contrary to the public interest. In highly engaging prose, they offer specific examples of how generic competition has been stifled for years, with costs climbing into the billions and everyday consumers paying the price. Drug Wars is a guide to the current landscape, a roadmap for reform, and a warning of what is to come. It should be read by policymakers, academics, patients, and anyone else concerned with the soaring costs of prescription drugs.
The Business of Healthcare Innovation
Author: Lawton R. BurnsPublisher: Cambridge University Press
ISBN: 9780521838986
Category : Business & Economics
Languages : en
Pages : 400
Book Description
The first wide-ranging analysis of business trends in the manufacturing segment of the health care industry.